CDC: Cases of Flu Continue to Increase Across America
Flu continues to spread throughout the United States and has reached elevated levels in nearly every state.
Vaccination
Protection Similar With Single, Multiple HPV Vaccine Doses
US women who have received one dose of HPV vaccine have similar protection as women who have received two or three doses.
First Ebola Vaccine Receives FDA Approval
The FDA has approved Ervebo (Ebola Zaire vaccine, live) for the prevention of disease caused by Zaire ebolavirus in individuals ≥18 years of age.
Extending HPV Vaccination to Age 45 Years Provides Small Additional Benefit
Vaccinating women and men up to age 45 years for HPV is predicted to have high costs per QALY gained.
Effects of Maternal Measles Antibodies on Response After Infant MMR Vaccination
Pre-existing low-avidity neutralizing maternal measles antibodies do not interfere with the development of high concentrations of high-avidity measles antibodies in children immunized at age 12 months.
Co-Administration of New Pneumococcal Vaccine Offers No Additional Protection Against Acute Otitis Media
An investigational pneumococcal protein-based vaccine co-administered with PCV13 was well-tolerated and immunogenic but did not show incremental efficacy in preventing AOM or acute lower respiratory tract infection in children.
GI.1 Virus Lot 001-09NV Aids Norovirus Vaccine Development
The Norwalk GI.1 virus Lot 001-09NV may be a useful challenge strain for future norovirus vaccine development.
First Ebola Vaccine Approved by European Commission
The world’s first Ebola vaccine has been approved by the European Commission, and it was quickly prequalified by the World Health Organization.
AHA: About One in Three With CVD Not Receiving Flu Shot
About one in three individuals with atherosclerotic cardiovascular disease (ASCVD) did not receive an influenza vaccination in the past year.
Effect of Legislation on School Vaccination Rates May Be Limited
Assuming the current rates of medical exemptions persist, the overall exemption rate in California schools is expected to stabilize at 1.87% by 2027.
Next post in Prevention
